To our knowledge, this is the first study demonstrating that DHA supplementation decreases expression of p-SREBP-1, m-SREBP-1, and FASN in insulin or E2 stimulated MCF-7 human breast cancer cells and that AA and OA have no such effect. Here, FASN is linked to breast cancer.